Ripple kopen? Dit zijn de mogelijkheden

Probiodrug Aandeel

4,70EUR 0,02EUR 0,32%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Probiodrug AG - Profiel

Probiodrug AG is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.

Aandeelhouder

Eigenaar in %
Andera Partners SCA9,67
JPMorgan Asset Management (UK) Ltd.2,88
Lupus alpha Asset Management AG0,61
Aviva Investors Global Services Ltd.0,52
Edmond de Rothschild Asset Management (Luxembourg) SA0,43
Schroder Investment Management Ltd.0,34
Bellevue Asset Management AG0,19
Banca Credinvest SA (Investment Management)0,15
OP Asset Management Ltd.0,00
APG Asset Management NV0,00
AXA Investment Managers UK Ltd.0,00
Freefloat0,00

Adres

Weinbergweg 22, 06120 Halle
Postbus:
Telefoon: 493455559900
Fax: 493455559901
Internet: http://www.probiodrug.de

Management

Erich Maximilian Platzer MD, PhD
Chairman-Supervisory Board
Michael Schaeffer, PhD
Chief Business Officer
Ulrich Dauer, PhD
Chief Executive Officer
Frank T. Weber, PhD
Chief Medical Officer
Jörg Neermann, PhD
Member-Supervisory Board
Charlotte Lohmann
Member-Supervisory Board
Dinnies Johannes von der Osten, PhD
Vice Chairman-Supervisory Board

Invoer toevoegen